Prof. Ho Leung Ng

Prof. Ho Leung Ng on Linkedin Prof. Ho Leung Ng on Twitter Prof. Ho Leung Ng

Prof. Ho Leung Ng is one of the three founding team members of the Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project and oversees the Peter Moss AML/ALL AI Student Program.

VIEW PROFILE

Prof. Ho Leung Ng
Prof. Ho Leung Ng on Linkedin Prof. Ho Leung Ng on Twitter Prof. Ho Leung Ng
393

Prof. Ho Leung Ng

Project Co-Founder, Student Mentor & R&D
Intel Software Innovator

Ho Leung Ng is Associate Professor of Biochemistry & Molecular Biophysics at Kansas State University. He received his BA at Harvard University, PhD at UCLA, and completed his postdoctoral fellowship at UC Berkeley. He worked for two years in the biotech industry directly under Nobel Laureate, Brian Kobilka, on G-protein coupled receptors.

Prof. Ng's primary research is on structure-based drug discovery for cancer, including machine learning aided drug discovery. Prof. Ng also works on developing new computational methods for molecular imaging and microscopy. Prof. Ng is a National Science Foundation CAREER Awardee. His lab placed first in the Open Source Malaria Drug Activity Prediction Challenge in 2016 and fourth in the Drug Design Data Resource Grand Challenge 4 on predicting BACE1 Inhibitor activity in 2018.

Prof. Ho Leung Ng is one of the three founding team members of the Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project.

  

Comments Via Facebook

  

Peter Moss AML/ALL AI Research Project

The Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project is an open source project with the goals of leveraging Artificial Intelligence to help detect AML/ALL and discover potential candidates for drugs to help combat the diseases.

This project is in memory of Peter Edward Moss who lost his battle with Acute Myeloid Leukemia in August 2019.

© Peter Moss AML & ALL AI Research Project 2018. All Rights Reserved.
This project is entirely volunteer and is not a registered Non Profit.
Contact | Terms & Conditions | Privacy & Cookie Policy | Disclaimer | High Level A+ Encryption